Last week in Berlin, our Medical R&D Director, Andrii Korol, presented at the DOG 2024, where leaders in the field gathered to discuss advancements in medical technology.
Andrii showcased the Ukrainian experience of leveraging AI technology for mass screening of diabetic retinopathy, a critical initiative during these challenging times. His presentation was part of an engaging session on AI, which also included topics like MRI analyses in endocrine orbitopathy, teleophthalmology, and OCT applications for age-related macular degeneration.
This event highlights the importance of innovation in healthcare, and CheckEye is proud to be at the forefront of these developments, driving solutions that make a real difference in patient outcomes.